Tamsulosin Hcl.,DUTASTERIDE - search results

United States - English - NLM (National Library of Medicine)

dutasteride and tamsulosin hydrochloride- dutasteride and tamsulosin hydrochloride capsule

actavis pharma, inc. - dutasteride (unii: o0j6xjn02i) (dutasteride - unii:o0j6xjn02i), tamsulosin hydrochloride (unii: 11sv1951mr) (tamsulosin - unii:g3p28oml5i) - dutasteride 0.5 mg - dutasteride and tamsulosin hydrochloride capsules are indicated for the treatment of symptomatic bph in men with an enlarged prostate. dutasteride-containing products, including dutasteride and tamsulosin hydrochloride capsules, are not approved for the prevention of prostate cancer. dutasteride and tamsulosin hydrochloride capsules are contraindicated for use in: - pregnancy. in animal reproduction and developmental toxicity studies, dutasteride inhibited development of male fetus external genitalia. therefore, dutasteride and tamsulosin hydrochloride capsules may cause fetal harm when administered to a pregnant woman. if dutasteride and tamsulosin hydrochloride capsules are used during pregnancy, or if the patient becomes pregnant while taking dutasteride and tamsulosin hydrochloride capsules, the patient should be apprised of the potential hazard to the fetus [see warnings and precautions (5.6), use in specific populations (8.1)] . - women of childbearing potential [see warnings and precautions (5.6), use

Malta - English - Medicines Authority

dutasteride/tamsulosin hydrochloride 0.5mg/0.4mg hard capsules

azure pharmaceuticals ltd 12 hamilton drive, the rock road, blackrock, co. louth a91 t997, ireland - dutasteride, tamsulosin hydrochloride - hard capsule - dutasteride 0.5 mg tamsulosin hydrochloride 0.4 mg - urologicals